Calcium or magnesium chloride salt-based composition
David A. Edwards, Cambridge, MA (US); Rachel Diane Field, Boston, MA (US); Thomas E. Devlin, Somerville, MA (US); and Dennis Arthur Ausiello, Wellesley Hills, MA (US)
Assigned to SENSORY CLOUD, INC., Boston, MA (US)
Filed by SENSORY CLOUD, INC., Boston, MA (US)
Filed on May 15, 2025, as Appl. No. 19/209,542.
Application 19/209,542 is a division of application No. 18/809,916, filed on Aug. 20, 2024.
Application 18/809,916 is a continuation in part of application No. 18/769,136, filed on Jul. 10, 2024.
Application 18/769,136 is a continuation of application No. 18/094,604, filed on Jan. 9, 2023, abandoned.
Application 18/769,136 is a continuation of application No. 17/139,401, filed on Dec. 31, 2020, abandoned.
Claims priority of provisional application 63/428,622, filed on Nov. 29, 2022.
Claims priority of provisional application 63/425,450, filed on Nov. 15, 2022.
Claims priority of provisional application 63/401,948, filed on Aug. 29, 2022.
Claims priority of provisional application 63/395,926, filed on Aug. 8, 2022.
Claims priority of provisional application 63/331,398, filed on Apr. 15, 2022.
Claims priority of provisional application 63/324,461, filed on Mar. 28, 2022.
Claims priority of provisional application 63/297,927, filed on Jan. 10, 2022.
Claims priority of provisional application 63/130,099, filed on Dec. 23, 2020.
Claims priority of provisional application 63/121,448, filed on Dec. 4, 2020.
Claims priority of provisional application 63/048,421, filed on Jul. 6, 2020.
1. A method of reducing coughing in an individual comprising administering by inhalation by the individual aerosolized droplets having a mass median aerodynamic diameter of between 8 and less than 15 microns of a sterile aqueous salt solution having a pH adjusted with a pH adjusting agent to between 7.5 and 10 and consisting of the pH adjusting agent and between 2% and 7% by weight of salt selected from the group consisting of CaCl2), MgCl2 and combinations thereof, in water.